“…Liu et al [ 7 ] recorded many compounds isolated from biogenic sources with anti-EV71 activity over the period between 2005–2015. Recently reported anti-EV agents include aminopyridyl 1,2,5-thiadiazolidine 1,1-dioxides [ 8 ], 3-aryl-1,2,4-oxadiazoles [ 7 ], benzothiophenes [ 9 ], N 6 -benzyladenosine [ 10 ], 3-benzyl-1,3-benz-oxazine-2,4-diones [ 11 ], biaryl-substituted quinolones [ 12 ], diarylhydrazides [ 13 ], disaccharide heparan sulfates [ 5 ], epidithiodiketopiperazines [ 14 ], isopentenyladenosine [ 15 ], α-keto amides [ 16 , 17 ], nitrobenzonitriles [ 18 ], peptidomimetic aldehydes [ 19 ], quinoline–thiophene conjugates [ 20 ], sophoridine alkaloid [ 21 ], stilbenoids [ 22 ], multi-tryptophan derivatives [ 23 ], and others.…”